JSS Barristers files Proposed Class Action Respecting Zofran
Jensen Shawa Solomon Duguid Hawkes LLP and Siskinds LLP have filed a class action lawsuit against GlaxoSmithKline for the production and distribution of the pharmaceutical drug ondansetron, marketed under the brand name Zofran. Zofran is advertised as an anti-nausea and vomiting drug for surgical patients and consumers suffering the effects of cancer treatment such as radiation and chemotherapy.
Zofran was marketed as a safe and effective treatment for nausea and vomiting during pregnancy, an off-label use. The Plaintiffs allege that the drug was never studied in pregnant women, and the drug is, in fact, not safe for use during the first trimester of pregnancy. In some circumstances offspring of women who consumed Zofran during the first trimester of pregnancy have suffered serious negative, and sometimes fatal, health consequences in utero.